JMDC Third Quarter 2025 Earnings: Misses Expectations

JMDC (TSE:4483) Third Quarter 2025 Results

Key Financial Results

• Revenue: JP¥11.4b (up 34% from 3Q 2024).
• Net income: JP¥1.67b (up 27% from 3Q 2024).
• Profit margin: 15% (in line with 3Q 2024).
• EPS: JP¥25.60 (up from JP¥20.14 in 3Q 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

JMDC Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 4.5%. Earnings per share (EPS) also missed analyst estimates by 27%.

Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Healthcare Services industry in Japan.

Performance of the Japanese Healthcare Services industry.

The company's shares are down 17% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with JMDC, and understanding them should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.